Home » Archive

Drug Discovery

Drug Discovery, News, Syndication, Xconomy »

Sanford-Burnham Joins Fold at Pfizer’s Centers for Therapeutic Innovation

Posted by sandiegobiotech November 3rd, 2011 .
No Comments

San Diego’s Sanford-Burnham Medical Research Institute says today it’s joining the Centers for Therapeutic Innovation (CTI), a global network that New York-based Pfizer established a year…

[[Click headline to continue reading.]]

More...

Drug Discovery, Featured, SDBN Blog, Uncategorized »

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

Posted by Lara July 28th, 2011 .
No Comments

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable insights and advice for scientists managing or considering how to manage an outsourced drug discovery project.
We’ve compiled some of the key tips and highlights of the night including:

What activities should you outsource?
Finding the right CRO for your objectives
Managing your CRO relationship successfully every time
Virtual tools to help manage and build your CRO network
Finding the funding …

More...

Drug Discovery, Headline, SDBN Blog, SDBN Events, Uncategorized »

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

Posted by Mary Canady July 1st, 2011 .
No Comments

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug companies are hungry for drug candidates to fill their pipelines. Additionally, the abundance of drug discovery contract research organizations (CROs), the ability to manage them remotely, and the ability to find partners and tools more easily on the internet presents an interesting opportunity.
Our July 19th event is our first in a series of Virtual Biotech …

More...

Drug Discovery, Headline, SDBN Blog, SDBN Events »

SDBN June 21st Event Featuring aTyr Pharma

Posted by Mary Canady May 27th, 2011 .
No Comments

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on physiocrines, small proteins involved in signaling pathways for areas such hematology, immunology, and metabolism disorders. The company was founded based on research which originated at the Scripps Research Institute, and Watkins’ title indicates the company is reaching beyond in vitro drug discovery to focus on biological processes. It will be exciting to see the …

More...

Drug Discovery, Headline, SDBN Events »

SDBN April 19th 2011 Event Featuring Celgene

Posted by Mary Canady March 22nd, 2011 .
No Comments

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one of the top ten fastest growing biotech stocks. Celgene has more than 4,000 employees worldwide, with important work being carried out at their San Diego location. David Webb, Vice President, Research & San Diego Site Director (Bio) will give a presentation titled “Celgene’s Drug Discovery Engine in San Diego” at our April 19th event.
As always, …

More...

Drug Discovery, Headline, SDBN Blog, SDBN Events, Uncategorized »

SDBN October 26th Event Featuring Trius Therapeutics

Posted by Mary Canady October 5th, 2010 .
No Comments

Trius Therapeutics is a great local company which recently had an initial public offering (IPO), quite a feat in this economy. What is the secret to their success? They focus on antibacterials for life threatening applications, and have used a creative combination of licensing and funding to build a strong portfolio in that area. Working with bacterial proteins helps Trius to leverage structure-based drug design (SBDD) technologies to efficiently optimize lead compounds. Dr. John Finn, Trius’ Chief Scientific Officer (bio), will present a talk titled “Innovative Antibacterial Drugs by Design; …

More...

Biotechnology, Drug Discovery, Headline, SDBN Blog, SDBN Events »

September 28th Event Sponsored by Halozyme Therapeutics

Posted by Mary Canady September 6th, 2010 .
No Comments

We’re going to try something new for the San Diego Biotechnology Network in September. The folks at Halozyme have offered to start hosting events quarterly at their site in Sorrento Valley, and we’ll kick of the first event learning about their exciting science September 28th. They focus on therapeutics that work subcutaneously by targeting the extracellular matrix (the image is from a mural in their lobby) and have had lots of great news lately, so it will be nice to hear more. As always we’ll have plenty of time for …

More...

Drug Discovery, Headline, SDBN Blog, SDBN Events, Uncategorized »

SDBN August 18th Event: The Human Genome 10 Years Later: What Does it Mean for San Diego Biotech?

Posted by Mary Canady July 23rd, 2010 .
No Comments

June 2010 marks the 10th anniversary of the sequencing of the human genome. As Francis Collins has pointed out, “we invariably overestimate the short-term impacts of new technologies and underestimate their longer-term effects.” As a member of the community for 14 years, I can tell you that this is true for San Diego, as the expectations in 2000 were likely too high, but the last ten years have brought unexpected progress in many areas.
San Diego has a great ecosystem to take advantage of these exciting longer-term benefits, ranging from our …

More...

Drug Discovery, Headline, SDBN Blog, SDBN Events »

SDBN July 21st Speed Networking Event Sponsored by Life Technologies

Posted by Mary Canady July 1st, 2010 .
No Comments

Our January Speed Networking event went so well that we promised we’d do it again so that you can meet as many local biotech professionals as possible in one night. How does it work? Check out our report of the last speed networking event for more details, and basically show up with plenty of business cards, something to take notes with, and craft a thirty second ‘elevator speech’ which describes who you are and what you’re looking for professionally. We always have a nice mix of professionals at our events, …

More...

Drug Discovery, Featured, SDBN Blog »

San Diego Stem Cell Coalition to Fight ALS: CIRM Update

Posted by Mary Canady June 30th, 2010 .
One Comment

The California Institute for Regenerative Medicine (CIRM) granted a local interdisciplinary research team from UCSD, Salk, and Life Technologies $11.5 million for research aimed at finding a cure for amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease. On June 23rd, CIRM hosted a public research update which I attended. The project is an excellent example of local research organizations and companies working together towards translating research into real cures, funded by California citizens who realize the promise of stem cell technologies.
The ALS team is led by Lawrence Goldstein, Ph.D., and …

More...